Carbon monoxide contributes to the constipating effects of granisetron in rat colon.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27895421)

Published in World J Gastroenterol on November 14, 2016

Authors

Carmela Nacci1, Margherita Fanelli1, Maria Assunta Potenza1, Valentina Leo1, Monica Montagnani1, Maria Antonietta De Salvia1

Author Affiliations

1: Carmela Nacci, Maria Assunta Potenza, Valentina Leo, Monica Montagnani, Maria Antonietta De Salvia, Department of Biomedical Sciences and Human Oncology - Pharmacology Section, Medical School, University of Bari "Aldo Moro", Piazza G. Cesare, 70124 Bari, Italy.

Articles cited by this

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet (2000) 10.36

Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev (2006) 7.76

Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev (2005) 2.73

5-HT3 receptors are membrane ion channels. Nature (1989) 2.21

Neuroeffector apparatus in gastrointestinal smooth muscle organs. J Physiol (2010) 1.85

Targeted gene deletion of heme oxygenase 2 reveals neural role for carbon monoxide. Proc Natl Acad Sci U S A (1997) 1.75

Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation (2010) 1.64

Carbon monoxide and nitric oxide as coneurotransmitters in the enteric nervous system: evidence from genomic deletion of biosynthetic enzymes. Proc Natl Acad Sci U S A (2000) 1.57

Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res (1998) 1.37

Postprandial colonic transit and motor activity in chronic constipation. Gastroenterology (1990) 1.27

Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting. N Engl J Med (2016) 1.22

Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch Pharmacol (2008) 1.18

Carbon monoxide, hydrogen sulfide, and nitric oxide as signaling molecules in the gastrointestinal tract. Gastroenterology (2014) 1.10

Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins. Gut (1995) 1.05

CrossTalk proposal: 5-HT is necessary for peristalsis. J Physiol (2015) 1.01

Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis. Neurochem Res (2001) 1.00

Serotonin (5-HT) release and uptake measured by real-time electrochemical techniques in the rat ileum. Am J Physiol Gastrointest Liver Physiol (2008) 1.00

CrossTalk opposing view: 5-HT is not necessary for peristalsis. J Physiol (2015) 1.00

Diverse mechanisms underlying the regulation of ion channels by carbon monoxide. Br J Pharmacol (2014) 0.95

The aging colon: the role of enteric neurodegeneration in constipation. Curr Gastroenterol Rep (2010) 0.94

Carbon monoxide activates human intestinal smooth muscle L-type Ca2+ channels through a nitric oxide-dependent mechanism. Am J Physiol Gastrointest Liver Physiol (2004) 0.94

Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human. Auton Neurosci (2006) 0.92

Impaired colonic motor response to eating in patients with slow-transit constipation. Am J Gastroenterol (1992) 0.92

Protocol to refine intestinal motility test in mice. Lab Anim (2004) 0.91

Carbon monoxide: an emerging regulator of ion channels. J Physiol (2011) 0.91

5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment. Oncology (2005) 0.89

The role of heme oxygenase in neuropathic and incisional pain. Anesth Analg (2000) 0.87

Review article: carbon monoxide in gastrointestinal physiology and its potential in therapeutics. Aliment Pharmacol Ther (2013) 0.85

Analysis of the bacterial response to Ru(CO)3Cl(Glycinate) (CORM-3) and the inactivated compound identifies the role played by the ruthenium compound and reveals sulfur-containing species as a major target of CORM-3 action. Antioxid Redox Signal (2013) 0.85

Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva). Pharmacol Biochem Behav (2011) 0.83

Idiopathic chronic constipation: tachykinins as cotransmitters in colonic contraction. Eur J Clin Invest (2001) 0.83

Tissue engineering for neuromuscular disorders of the gastrointestinal tract. World J Gastroenterol (2012) 0.82

Modulation of ion channels and transporters by carbon monoxide: causes for concern? Front Physiol (2012) 0.82

Induction of heme oxygenase-1 improves impaired intestinal transit after burn injury. Surgery (2006) 0.81

Enteric Dysfunctions in Experimental Parkinson's Disease: Alterations of Excitatory Cholinergic Neurotransmission Regulating Colonic Motility in Rats. J Pharmacol Exp Ther (2015) 0.79

Modulation of neurotransmitter release by carbon monoxide at the frog neuro-muscular junction. Curr Drug Metab (2007) 0.79

Activation of 5-HT3 receptors in the rat and mouse intestinal tract: a comparative study. Br J Pharmacol (2006) 0.79

Hemin and Zinc Protoporphyrin IX Affect Granisetron Constipating Effects In Vitro and In Vivo. ISRN Gastroenterol (2013) 0.77

Prostaglandin I(2) sensory input into the enteric nervous system during distension-induced colonic chloride secretion in rat colon. Acta Physiol (Oxf) (2010) 0.77

Targeting of heme oxygenase-1 as a novel immune regulator of neuroblastoma. Int J Cancer (2015) 0.77

A non-invasive method to evaluate gastrointestinal transit behavior in rat. J Pharmacol Toxicol Methods (2015) 0.76

Characterization of the motor inhibitory role of colonic mucosa under chemical stimulation in mice. Am J Physiol Gastrointest Liver Physiol (2014) 0.76